Tetrahydroaminoacridine and physostigmine have opposing effects on probability of transmitter release at the frog neuromuscular junction
- 11 February 1991
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 123 (1) , 127-130
- https://doi.org/10.1016/0304-3940(91)90174-r
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine.BMJ, 1990
- An electrophysiological study of 9-amino-1,2,3,4-tetrahydroacridine (THA) on sino-atrial node preparations of rabbitsGeneral Pharmacology: The Vascular System, 1990
- Tetrahydroaminoacridine but not 4-aminopyridine inhibits high-affinity choline uptake in striatal and hippocampal synaptosomesBrain Research, 1989
- Probability of quantal transmitter release from nerve terminals: Theoretical considerations in the determination of spatial variationJournal of Theoretical Biology, 1986
- Alzheimer's DiseaseNew England Journal of Medicine, 1986
- The 12th J. A. F. Stevenson Memorial Lecture: Aging, Alzheimer's disease, and the cholinergic systemCanadian Journal of Physiology and Pharmacology, 1984
- FURTHER COMPARISON OF THE EFFECTS OF PHYSOSTIGMINE AND NEOSTIGMINE ON FROG NEUROMUSCULAR TRANSMISSIONClinical and Experimental Pharmacology and Physiology, 1982
- Physostigmine, but not neostigmine, inhibits acetylcholine releaseBrain Research, 1979
- On the factors which determine the amplitude of the ‘miniature end‐plate potential’The Journal of Physiology, 1957